Leng Jian-Jun, Zhang Ning, Dong Jia-Hong
World J Surg Oncol. 2014;12(1):272. doi: 10.1186/1477-7819-12-272. Epub 2014 Aug 23.
Various malignant tumors can obstruct the extrahepatic biliary tract. Two major techniques for restoring bile flow in this circumstance are endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD).We conducted a meta-analysis to compare the effectiveness and safety of the two techniques.
Medline, EMBASE and the Cochrane Library database were searched for articles published between January 1980 and December 2013. The outcome measures were therapeutic success rate (primary), 30-day mortality rate and overall complications.
Of 264 screened articles, 3 randomized controlled trialscomprising an aggregate total of 183 cancer patients were included in the meta-analysis. Our analysis showed no significant difference in restoration of bile flow between patients treated with EBD and those treated with PTBD (odds ratio (OR) = 2.34, 95% confidence interval (CI) = 0.32 to 17.16, P = 0.401).However, the result of sensitivity analysis indicated that the study conducted by Speer et al. influenced the pooled estimates. After the Speer et al. study was excluded, the therapeutic success rate of patients treated with PTBD was significantly greater than that of those who underwent EBD (OR = 5.48, 95% CI: 2.26 to 13.28, P < 0.001). The 30-day mortality and complication rates were similar in the EBD and PTBD groups.
The results of our meta-analysis indicate that PTBD had a higher therapeutic success rate than EBD in the treatment of malignancy-induced biliary obstruction. The mortality and complication rates of the two techniques were similar.
多种恶性肿瘤可阻塞肝外胆道。在这种情况下,恢复胆汁流动的两种主要技术是内镜下胆道引流(EBD)和经皮经肝胆道引流(PTBD)。我们进行了一项荟萃分析,以比较这两种技术的有效性和安全性。
检索Medline、EMBASE和Cochrane图书馆数据库中1980年1月至2013年12月发表的文章。结局指标为治疗成功率(主要指标)、30天死亡率和总体并发症。
在264篇筛选的文章中,3项随机对照试验共纳入183例癌症患者进行荟萃分析。我们的分析显示,接受EBD治疗的患者和接受PTBD治疗的患者在胆汁流动恢复方面无显著差异(优势比(OR)=2.34,95%置信区间(CI)=0.32至17.16,P = 0.401)。然而,敏感性分析结果表明,Speer等人进行的研究影响了汇总估计值。排除Speer等人的研究后,接受PTBD治疗的患者的治疗成功率显著高于接受EBD治疗的患者(OR = 5.48,95% CI:2.26至13.28,P < 0.001)。EBD组和PTBD组的30天死亡率和并发症发生率相似。
我们的荟萃分析结果表明,在治疗恶性肿瘤引起的胆道梗阻方面,PTBD的治疗成功率高于EBD。两种技术的死亡率和并发症发生率相似。